Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(DL-lactide-co-glycolide) block copolymer

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages

  Kim, Do Hyung ^a,b   Kim, Min Dae ^c   Choi, Cheol Woong ^c   Chung, Chung Wook ^a   Ha, Seung Hee ^a   Kim, Cy Hyun ^a,b   Shim, Yong Ho ^a   Jeong, Young Il ^a   Kang, Dae Hwan ^a,b  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Dextran; Poly(DL lactide co glycolide); Polymeric micelle; Sorafenib

Indexed keywords

BLOCK COPOLYMERS; CONTROLLED DRUG DELIVERY; DEXTRAN; DRUG PRODUCTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MICELLES; TARGETED DRUG DELIVERY;

ANTI-TUMOR ACTIVITIES; ANTITUMOR DRUG DELIVERIES; CHOLANGIOCARCINOMA; NANO PRECIPITATIONS; NANOPARTICLE SIZES; POLY(DL-LACTIDE-COGLYCOLIDE); POLYMERIC MICELLE; SORAFENIB;

NANOPARTICLES;

EID: 84863258004     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-91     Document Type: Article

References (14)

1. Allemann E, Gurny R, Doelker E: Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: purification of an injected dosage form. Eur J Pharm Biopharm 1993, 39:173-191.
2. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R: Biodegradable long-circulating polymeric nanospheres. Science 1994, 263:1600-1603.
3. La SB, Okano T, Kataoka K: Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl Laspartate) block copolymer micelles. J Pharm Sci 1996, 85:85-90.
4. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K: Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res 1995, 12:192-195.
5. Kwon GS, Naito M, Yokoyama M: Micelles based on AB block copolymers of poly(ethylene oxide) and poly(ß-benzyl L-aspartate). Langmuir 1993, 9:945-949.
6. Kwon GS, Yokoyama M, Okano T, Sakurai Y, Kataoka K: Biodistribution of micelleforming polymer-drug conjugates. Pharm Res 1993, 10:970-974.
7. Seehofer D, Kamphues C, Neuhaus P: Management of bile duct tumors. Expert OpinPharmacother 2008, 9:2843-2856.
8. Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M: Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 2008, 7:3129-3140.
9. Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C: Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006, 66:11851-11858.
10. Qun W, Tao Y: Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China. Hepatogastroenterology 2010, 57:426-429.
11. Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR: Zhang Q: Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm 2011, 419:339-346.
12. Zhang JY, He B, Qu W, Cui Z, Wang YB, Zhang H, Wang JC, Zhang Q: Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo. J Microencapsul 2011, 28:528-536.
13. Jeong YI, Kim DH, Chung CW, Yoo JJ, Choi KH, Kim CH, Ha SH, Kang DH: Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactideco- glycolide) copolymer. Int J Nanomedicine 2011, 6:1415-1427.
14. Jeong YI, Kim DG, Jang MK, Nah JW, Kim YB: All-trans retinoic acid release from surfactant-free nanoparticles of poly(DL-lactide-co-glycolide). Macromol Res 2008, 16:717-724.